ARM Innovation Hub
Advertisement Cambridge China Centre
Advertisement: RSM
Advertisement: TTP
Advertisement: Cambridge Network
RealVNC mid banner careers
Advertisement EY mid banner
RealVNC mid-banner general
Advertisement: Bradfield Centre mid
Mid banner advertisement: BDO
Barr Ellison Solicitors – commercial property
Advertisement: Wild Knight Vodka
Advertisement: Mogrify
4 November, 2011 - 15:44 By News Desk

Novel markers for the diagnosis and prognosis of breast cancer

Novel markers for the diagnosis and prognosis of breast cancer

A German university has found out that two proteins may serve as novel markers for the diagnosis and prognosis of breast cancer. They may be used for the determination of a patient`s prognosis and for a therapy efficacy within the scope of personalised medicine. Cost-effective breast cancer tests are possible, convenient for patients due to easy access and applicable to young and old patients. A patent license and/or research collaboration is offered to innovative pharma / biotech companies.Ref: 11 DE 0855 3N09

Add new comment

Newsletter Subscription

Stay informed of the latest news and features